[1] |
Aas JA, Paster BJ, Stokes LN, et al.Defining the normal bacterial flora of the oral cavity[J]. J Clin Microbiol, 2005, 43(11): 5721-5732.
|
[2] |
Teng F, Yang F, Huang S, et al.Prediction of early childhood caries via spatial-temporal variations of oral microbiota[J]. Cell Host Microbe, 2015, 18(3): 296-306.
|
[3] |
Hajishengallis G, Liang S, Payne MA, et al.Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement[J]. Cell Host Microbe, 2011, 10(5): 497-506.
|
[4] |
Pushalkar S, Ji X, Li Y, et al.Comparison of oral microbiota in tumor and non-tumor tissues of patients with oral squa-mous cell carcinoma[J]. BMC Microbiol, 2012, 12: 144.
|
[5] |
Hu X, Zhang Q, Hua H, et al.Changes in the salivary micro-biota of oral leukoplakia and oral cancer[J]. Oral Oncol, 2016, 56: e6-e8.
|
[6] |
Gallimidi AB, Fischman S, Revach B, et al.Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model[J]. Oncotarget, 2015, 6(26): 22613-22623.
|
[7] |
Zhang X, Zhang D, Jia H, et al.The oral and gut microbio-mes are perturbed in rheumatoid arthritis and partly norma-lized after treatment[J]. Nat Med, 2015, 21(8): 895-905.
|
[8] |
Han YW.Oral health and adverse pregnancy outcomes- what’s next[J]. J Dent Res, 2011, 90(3): 289-293.
|
[9] |
Han YW, Wang X.Mobile microbiome: oral bacteria in extra-oral infections and inflammation[J]. J Dent Res, 2013, 92(6): 485-491.
|
[10] |
Chen X, Yuan Z, Lu M, et al.Poor oral health is associated with an increased risk of esophageal squamous cell carci-noma—a population-based case-control study in China[J]. Int J Cancer, 2017, 140(3): 626-635.
|
[11] |
Nasrollahzadeh D, Malekzadeh R, Aghcheli K, et al.Gastric atrophy and oesophageal squamous cell carcinoma: possible interaction with dental health and oral hygiene habit[J]. Br J Cancer, 2012, 107(5): 888-894.
|
[12] |
Sepehr A, Kamangar F, Fahimi S, et al.Poor oral health as a risk factor for esophageal squamous dysplasia in northea-stern Iran[J]. Anticancer Res, 2005, 25(1B): 543-546.
|
[13] |
Sato F, Oze I, Kawakita D, et al.Inverse association between toothbrushing and upper aerodigestive tract cancer risk in a Japanese population[J]. Head Neck, 2011, 33(11): 1628-1637.
|
[14] |
Ahn J, Segers S, Hayes RB.Periodontal disease, Porphyro-monas gingivalis serum antibody levels and orodigestive cancer mortality[J]. Carcinogenesis, 2012, 33(5): 1055-1058.
|
[15] |
Chen X, Winckler B, Lu M, et al.Oral microbiota and risk for esophageal squamous cell carcinoma in a high-risk area of China[J]. PLoS One, 2015, 10(12): e0143603.
|
[16] |
Gao S, Li S, Ma Z, et al.Presence of Porphyromonas gin-givalis in esophagus and its association with the clinicopatho-logical characteristics and survival in patients with esopha-geal cancer[J]. Infect Agents Cancer, 2016, 11: 3.
|
[17] |
Muto M, Hitomi Y, Ohtsu A, et al.Acetaldehyde production by non-pathogenic Neisseria in human oral microflora: imp-lications for carcinogenesis in upper aerodigestive tract[J]. Int J Cancer, 2000, 88(3): 342-350.
|
[18] |
Fan X, Alekseyenko AV, Wu J, et al.Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study[J]. Gut, 2018, 67(1): 120-127.
|
[19] |
Michaud DS, Joshipura K, Giovannucci E, et al.A prospec-tive study of periodontal disease and pancreatic cancer in US male health professionals[J]. J Natl Cancer Inst, 2007, 99(2): 171-175.
|
[20] |
Chang JS, Tsai CR, Chen LT, et al.Investigating the asso-ciation between periodontal disease and risk of pancreatic cancer[J]. Pancreas, 2016, 45(1): 134-141.
|
[21] |
Torres PJ, Fletcher EM, Gibbons SM, et al.Characterization of the salivary microbiome in patients with pancreatic cancer[J]. PeerJ, 2015, 3: e1373.
|
[22] |
Michaud DS, Izard J, Wilhelm-Benartzi CS, et al.Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study[J]. Gut, 2013, 62(12): 1764-1770.
|
[23] |
Atanasova KR, Yilmaz Ö.Prelude to oral microbes and chronic diseases: past, present and future[J]. Microb Infect, 2015, 17(7): 473-483.
|
[24] |
Le Roy T, Llopis M, Lepage P, et al.Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice[J]. Gut, 2013, 62(12): 1787-1794.
|
[25] |
Llopis M, Cassard AM, Wrzosek L, et al.Intestinal micro-biota contributes to individual susceptibility to alcoholic liver disease[J]. Gut, 2016, 65(5): 830-839.
|
[26] |
Lu H, Ren Z, Li A, et al.Deep sequencing reveals microbiota dysbiosis of tongue coat in patients with liver carcinoma[J]. Sci Rep, 2016, 6: 33142.
|
[27] |
Bajaj JS, Betrapally NS, Hylemon PB, et al.Salivary micro-biota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy[J]. Hepatology, 2015, 62(4): 1260-1271.
|
[28] |
Qin N, Yang F, Li A, et al.Alterations of the human gut microbiome in liver cirrhosis[J]. Nature, 2014, 513(7516): 59-64.
|
[29] |
Nakajima M, Arimatsu K, Kato T, et al.Oral administration of P. gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of entero-bacteria to the liver[J]. PLoS One, 2015, 10(7): e0134234.
|
[30] |
Arimatsu K, Yamada H, Miyazawa H, et al.Oral pathobiont induces systemic inflammation and metabolic changes asso-ciated with alteration of gut microbiota[J]. Sci Rep, 2014, 4: 4828.
|
[31] |
Seedorf H, Griffin NW, Ridaura VK, et al.Bacteria from diverse habitats colonize and compete in the mouse gut[J]. Cell, 2014, 159(2): 253-266.
|
[32] |
Ray K.IBD. Gut microbiota in IBD goes viral[J]. Nat Rev Gastroenterol Hepatol, 2015, 12(3): 122.
|
[33] |
Said HS, Suda W, Nakagome S, et al.Dysbiosis of salivary microbiota in inflammatory bowel disease and its association with oral immunological biomarkers[J]. DNA Res, 2014, 21(1): 15-25.
|
[34] |
Ismail Y, Mahendran V, Octavia S, et al.Investigation of the enteric pathogenic potential of oral campylobacter con-cisus strains isolated from patients with inflammatory bowel disease[J]. PLoS One, 2012, 7(5): e38217.
|
[35] |
Strauss J, Kaplan GG, Beck PL, et al.Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host[J]. Inflamm Bowel Dis, 2011, 17(9): 1971-1978.
|
[36] |
Castellarin M, Warren RL, Freeman JD, et al.Fusobacterium nucleatum infection is prevalent in human colorectal car-cinoma[J]. Genome Res, 2012, 22(2): 299-306.
|
[37] |
Kostic AD, Gevers D, Pedamallu CS, et al.Genomic analysis identifies association of Fusobacterium with colorectal car-cinoma[J]. Genome Res, 2012, 22(2): 292-298.
|
[38] |
Chen W, Liu F, Ling Z, et al.Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer[J]. PLoS One, 2012, 7(6): e39743.
|
[39] |
Rubinstein MR, Wang X, Liu W, et al.Fusobacterium nuclea-tum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin[J]. Cell Host Microbe, 2013, 14(2): 195-206.
|
[40] |
Gur C, Ibrahim Y, Isaacson B, et al.Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack[J]. Immunity, 2015, 42(2): 344-355.
|
[41] |
Kostic A, Chun E, Robertson L, et al.Fusobacterium nuclea-tum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment[J]. Cell Host Microbe, 2013, 14(2): 207-215.
|
[42] |
Abed J, Emgård JM, Zamir G, et al.Fap2 mediates Fuso-bacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc[J]. Cell Host Microbe, 2016, 20(2): 215-225.
|
[43] |
Kamada N, Seo SU, Chen GY, et al.Role of the gut micro-biota in immunity and inflammatory disease[J]. Nat Rev Immunol, 2013, 13(5): 321-335.
|
[44] |
Turnbaugh PJ, Ridaura VK, Faith JJ, et al. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice[J]. Sci Transl Med, 2009, 1(6): 6ra14.
|
[45] |
Arrieta MC, Walter J, Finlay BB.Human microbiota-asso-ciated mice: a model with challenges[J]. Cell Host Microbe, 2016, 19(5): 575-578.
|